Physician profile
Kaitlyn Ferrill
NPI 1720435597
$3,956.04
in general payments reported to CMS, 2019-2025
28 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.38 · 2020: $49.75 · 2021: $349 · 2022: $522 · 2023: $788 · 2024: $1,108 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,906 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,905.67 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $952.39 | 2020-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Astellas Pharma US INC | $417.20 | 2022-2025 | Veozah, Myrbetriq |
| Amgen INC. | $376.41 | 2021-2025 | Evenity, Prolia, Prolia |
| Sumitomo Pharma America, INC. | $373.25 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $313.98 | 2020-2025 | |
| Pfizer INC. | $236.27 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $158.64 | 2021-2025 | |
| Evofem Biosciences, INC. | $120.00 | 2021-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $116.40 | 2023-2025 | Paragard T 380a, Endosee |
| Exact Sciences Corporation | $114.36 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $105.55 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $90.35 | 2023-2025 | |
| Myovant Sciences INC. | $77.76 | 2022 | |
| Cytyc Surgical Products, LLC | $67.07 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Novasure, Acessa Provu System |
| Shield Therapeutics INC | $59.91 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $56.38 | 2019 | |
| Merck Sharp & Dohme LLC | $46.54 | 2021-2024 | Gardasil 9, Gardasil |
| Millicent US INC | $37.71 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Sage Therapeutics, LLC | $33.90 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $33.02 | 2021-2022 | |
| Therapeuticsmd, INC. | $28.53 | 2021 | |
| Agile Therapeutics, INC. | $28.45 | 2021 | |
| Organon LLC | $23.92 | 2021-2022 | |
| Medtronic, INC. | $20.41 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.69 | 2025 | Qelbree |
| Cumberland Pharmaceuticals, INC. | $17.73 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.35 | 2025 | |
| Antares Pharma, INC. | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Ferrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.